SlideShare una empresa de Scribd logo
1 de 42
Vasopeptidase Inhibition: A New Direction in Cardiovascular Treatment  . By: Dr. HARMANJIT SINGH  MD STUDENT , GMC , PATIALA
INTRODUCTION ,[object Object],[object Object],[object Object]
[object Object],[object Object]
Risk stratification in patients with hypertension Risk Group A Risk Group B Risk Group C  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment strategies by risk stratification and risk group categories in patients with hypertension  BP stages  (mm Hg)  Treatment Strategy  Risk Group A  Risk Group B  Risk Group C  High-Normal (130-139 / 85-89)  Lifestyle modification  Lifestyle modification  Drug therapy, Lifestyle modification  Stage 1 (140-159 / 90-99)  Lifestyle modification upto 12 months  Lifestyle modification upto 6 months  (patients with multiple factors should receive drug therapy + lifestyle modification) Drug therapy, lifestyle modification  Stage 2 & 3 (> 160 / > 100)  Drug therapy, lifestyle modification  Drug therapy + lifestyle modification  Drug therapy + lifestyle modification
[object Object],[object Object],[object Object]
Renin-Angiotensin System  ,[object Object],[object Object],[object Object]
Figure 1 showing role of RAS system in cardiovascular disease
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],Hope Cntd……
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],Natriuretic Pep Ctnd……
[object Object],[object Object],[object Object],[object Object],[object Object],There is also a forth natriuretic peptide known as dendroaspis natriuretic peptide (DNP), isolated from the venom of the green Mamba snake but little is known about it.
[object Object],[object Object],[object Object]
Figure 2 showing the benefits of inhibiting NEP
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
Figure 3 showing combined pathways involved in vasopeptidase inhibition
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
Other  Trials ,[object Object]
[object Object],[object Object],[object Object]
 
[object Object],[object Object]
[object Object],[object Object],[object Object]
Adverse effects of VPIs ,[object Object],[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object]
Conclusion ,[object Object],[object Object],[object Object]
[object Object]
Thanks

Más contenido relacionado

La actualidad más candente

Anticancer drugs persentation
Anticancer drugs persentationAnticancer drugs persentation
Anticancer drugs persentationROHIT PAL
 
Pharmacology of Proteins and peptides
Pharmacology of Proteins and peptidesPharmacology of Proteins and peptides
Pharmacology of Proteins and peptidesKoppala RVS Chaitanya
 
ANTIOXIDANTS FOR HEPATIC CIRRHOSIS.pptx
ANTIOXIDANTS FOR HEPATIC CIRRHOSIS.pptxANTIOXIDANTS FOR HEPATIC CIRRHOSIS.pptx
ANTIOXIDANTS FOR HEPATIC CIRRHOSIS.pptxPriyansha Singh
 
IMMUNOPHARMACOLOGY.pdf
IMMUNOPHARMACOLOGY.pdfIMMUNOPHARMACOLOGY.pdf
IMMUNOPHARMACOLOGY.pdfRAMDAS BHAT
 
Serotonin & migraine
Serotonin & migraineSerotonin & migraine
Serotonin & migraineAshfaq Ahmad
 
Screening methods of anti hypertensive agents
Screening methods of anti hypertensive agentsScreening methods of anti hypertensive agents
Screening methods of anti hypertensive agentsSwaroopaNallabariki
 
Introduction to ans, cholinergics system
Introduction to ans, cholinergics systemIntroduction to ans, cholinergics system
Introduction to ans, cholinergics systemSubramani Parasuraman
 
Sumatriptan and migraine
Sumatriptan and migraineSumatriptan and migraine
Sumatriptan and migrainekaxcha
 
NMDA receptors and drugs acting on them
NMDA receptors and drugs acting on themNMDA receptors and drugs acting on them
NMDA receptors and drugs acting on themDr. Pooja
 
Quantitative aspects of drug receptor interaction
Quantitative aspects of drug receptor interactionQuantitative aspects of drug receptor interaction
Quantitative aspects of drug receptor interactionDrSahilKumar
 
Drugs Acting on PPAR
Drugs Acting on PPARDrugs Acting on PPAR
Drugs Acting on PPARRichin Koshy
 

La actualidad más candente (20)

Antiulcer
AntiulcerAntiulcer
Antiulcer
 
Spare receptors
Spare receptorsSpare receptors
Spare receptors
 
Bioassay
BioassayBioassay
Bioassay
 
Anticancer drugs persentation
Anticancer drugs persentationAnticancer drugs persentation
Anticancer drugs persentation
 
Tetracyclines
TetracyclinesTetracyclines
Tetracyclines
 
Pharmacology of Proteins and peptides
Pharmacology of Proteins and peptidesPharmacology of Proteins and peptides
Pharmacology of Proteins and peptides
 
Antiulcer drugs
Antiulcer drugsAntiulcer drugs
Antiulcer drugs
 
ANTIOXIDANTS FOR HEPATIC CIRRHOSIS.pptx
ANTIOXIDANTS FOR HEPATIC CIRRHOSIS.pptxANTIOXIDANTS FOR HEPATIC CIRRHOSIS.pptx
ANTIOXIDANTS FOR HEPATIC CIRRHOSIS.pptx
 
IMMUNOPHARMACOLOGY.pdf
IMMUNOPHARMACOLOGY.pdfIMMUNOPHARMACOLOGY.pdf
IMMUNOPHARMACOLOGY.pdf
 
Serotonin & migraine
Serotonin & migraineSerotonin & migraine
Serotonin & migraine
 
Screening methods of anti hypertensive agents
Screening methods of anti hypertensive agentsScreening methods of anti hypertensive agents
Screening methods of anti hypertensive agents
 
Introduction to ans, cholinergics system
Introduction to ans, cholinergics systemIntroduction to ans, cholinergics system
Introduction to ans, cholinergics system
 
Sumatriptan and migraine
Sumatriptan and migraineSumatriptan and migraine
Sumatriptan and migraine
 
NMDA receptors and drugs acting on them
NMDA receptors and drugs acting on themNMDA receptors and drugs acting on them
NMDA receptors and drugs acting on them
 
Chronopharmacology
ChronopharmacologyChronopharmacology
Chronopharmacology
 
Quantitative aspects of drug receptor interaction
Quantitative aspects of drug receptor interactionQuantitative aspects of drug receptor interaction
Quantitative aspects of drug receptor interaction
 
Para sympathomimetics
Para sympathomimeticsPara sympathomimetics
Para sympathomimetics
 
SEROTONIN (VK)
SEROTONIN (VK)SEROTONIN (VK)
SEROTONIN (VK)
 
Drugs Acting on PPAR
Drugs Acting on PPARDrugs Acting on PPAR
Drugs Acting on PPAR
 
Sodium channel modulators
Sodium channel modulatorsSodium channel modulators
Sodium channel modulators
 

Destacado

Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...Govt Medical College & Hospital, Sector-32
 
MANAGEMENT OF CHLOROQUINE RESISTANT MALARIA BY Dr.HARMANJIT SINGH , DEPARTMEN...
MANAGEMENT OF CHLOROQUINE RESISTANT MALARIA BY Dr.HARMANJIT SINGH , DEPARTMEN...MANAGEMENT OF CHLOROQUINE RESISTANT MALARIA BY Dr.HARMANJIT SINGH , DEPARTMEN...
MANAGEMENT OF CHLOROQUINE RESISTANT MALARIA BY Dr.HARMANJIT SINGH , DEPARTMEN...Govt Medical College & Hospital, Sector-32
 
Evaluation of Drugs used in CCF
Evaluation of Drugs used in CCFEvaluation of Drugs used in CCF
Evaluation of Drugs used in CCFDr Ketan Asawalle
 
Respiratorysystemdock 131210122437-phpapp02
Respiratorysystemdock 131210122437-phpapp02Respiratorysystemdock 131210122437-phpapp02
Respiratorysystemdock 131210122437-phpapp02Sayeed Ahmad
 
Newer immunosuppressive drugs in renal tranplantation
Newer immunosuppressive drugs in renal tranplantationNewer immunosuppressive drugs in renal tranplantation
Newer immunosuppressive drugs in renal tranplantationSanjeev Nair
 
Anti malarial models
Anti malarial modelsAnti malarial models
Anti malarial modelsPruthvi Reddy
 
Alternative medicines
Alternative medicinesAlternative medicines
Alternative medicinesReema Jagtap
 
hiv and new category of anti hiv drugs in clinical trial
hiv and new category of anti hiv drugs in clinical trialhiv and new category of anti hiv drugs in clinical trial
hiv and new category of anti hiv drugs in clinical trialARUP SAHA
 
Physiology copy - copy
Physiology   copy - copyPhysiology   copy - copy
Physiology copy - copySayeed Ahmad
 
poster presentation.ppt BIOPHARMACEUTICALS.
poster presentation.ppt BIOPHARMACEUTICALS.poster presentation.ppt BIOPHARMACEUTICALS.
poster presentation.ppt BIOPHARMACEUTICALS.Nadia Jawaid
 
Newer Psychoactive Substances & Club Drugs
Newer Psychoactive Substances & Club DrugsNewer Psychoactive Substances & Club Drugs
Newer Psychoactive Substances & Club DrugsAshutosh Ratnam
 

Destacado (20)

Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
Thalidomide & its derivatives by Dr. Harmanjit Singh, Department of Pharmacol...
 
Recent advances in Antibacterials by Dr.Harmanjit Singh, GMC, Patiala
Recent advances in Antibacterials by Dr.Harmanjit Singh, GMC, PatialaRecent advances in Antibacterials by Dr.Harmanjit Singh, GMC, Patiala
Recent advances in Antibacterials by Dr.Harmanjit Singh, GMC, Patiala
 
MANAGEMENT OF CHLOROQUINE RESISTANT MALARIA BY Dr.HARMANJIT SINGH , DEPARTMEN...
MANAGEMENT OF CHLOROQUINE RESISTANT MALARIA BY Dr.HARMANJIT SINGH , DEPARTMEN...MANAGEMENT OF CHLOROQUINE RESISTANT MALARIA BY Dr.HARMANJIT SINGH , DEPARTMEN...
MANAGEMENT OF CHLOROQUINE RESISTANT MALARIA BY Dr.HARMANJIT SINGH , DEPARTMEN...
 
Management of rheumatoid arthritis .by Dr.Harmanjit Singh,GMC, Patiala
Management of rheumatoid arthritis .by Dr.Harmanjit Singh,GMC, PatialaManagement of rheumatoid arthritis .by Dr.Harmanjit Singh,GMC, Patiala
Management of rheumatoid arthritis .by Dr.Harmanjit Singh,GMC, Patiala
 
Monoclonal Antibodies and their role in Pharmacology
Monoclonal Antibodies and their role in Pharmacology  Monoclonal Antibodies and their role in Pharmacology
Monoclonal Antibodies and their role in Pharmacology
 
Mood disorders
Mood disordersMood disorders
Mood disorders
 
Evaluation of Drugs used in CCF
Evaluation of Drugs used in CCFEvaluation of Drugs used in CCF
Evaluation of Drugs used in CCF
 
Respiratorysystemdock 131210122437-phpapp02
Respiratorysystemdock 131210122437-phpapp02Respiratorysystemdock 131210122437-phpapp02
Respiratorysystemdock 131210122437-phpapp02
 
Newer immunosuppressive drugs in renal tranplantation
Newer immunosuppressive drugs in renal tranplantationNewer immunosuppressive drugs in renal tranplantation
Newer immunosuppressive drugs in renal tranplantation
 
Magnetism 3243
Magnetism 3243Magnetism 3243
Magnetism 3243
 
Recent advances in hplc and gc
Recent advances in hplc and gcRecent advances in hplc and gc
Recent advances in hplc and gc
 
Anti malarial models
Anti malarial modelsAnti malarial models
Anti malarial models
 
Alternative medicines
Alternative medicinesAlternative medicines
Alternative medicines
 
hiv and new category of anti hiv drugs in clinical trial
hiv and new category of anti hiv drugs in clinical trialhiv and new category of anti hiv drugs in clinical trial
hiv and new category of anti hiv drugs in clinical trial
 
Anticoagulant
AnticoagulantAnticoagulant
Anticoagulant
 
Physiology copy - copy
Physiology   copy - copyPhysiology   copy - copy
Physiology copy - copy
 
poster presentation.ppt BIOPHARMACEUTICALS.
poster presentation.ppt BIOPHARMACEUTICALS.poster presentation.ppt BIOPHARMACEUTICALS.
poster presentation.ppt BIOPHARMACEUTICALS.
 
Newer advances in la
Newer advances in laNewer advances in la
Newer advances in la
 
Newer antibiotics
Newer antibioticsNewer antibiotics
Newer antibiotics
 
Newer Psychoactive Substances & Club Drugs
Newer Psychoactive Substances & Club DrugsNewer Psychoactive Substances & Club Drugs
Newer Psychoactive Substances & Club Drugs
 

Similar a Dr. harman vasopeptidase inhibition

ARNI in Heart Failure Management
ARNI in Heart Failure ManagementARNI in Heart Failure Management
ARNI in Heart Failure ManagementBibul2
 
Hypertension according to latest clinical advances
Hypertension according to latest clinical advances Hypertension according to latest clinical advances
Hypertension according to latest clinical advances Arbeena Shakir
 
2. Antihypertensive Drugs-MSN.pdf
2. Antihypertensive Drugs-MSN.pdf2. Antihypertensive Drugs-MSN.pdf
2. Antihypertensive Drugs-MSN.pdfAqsaMushtaq32
 
Cardio-Renal Protection Through Renin–Angiotensin–Aldosterone System Inhibition
Cardio-Renal Protection Through Renin–Angiotensin–Aldosterone System InhibitionCardio-Renal Protection Through Renin–Angiotensin–Aldosterone System Inhibition
Cardio-Renal Protection Through Renin–Angiotensin–Aldosterone System Inhibitionmagdy elmasry
 
Rupajit Bhattacharjee hypertension management
Rupajit Bhattacharjee hypertension management Rupajit Bhattacharjee hypertension management
Rupajit Bhattacharjee hypertension management RupajitBhattacharjee1
 
Abnormalities of cardiac hormones...pdf
Abnormalities of cardiac hormones...pdfAbnormalities of cardiac hormones...pdf
Abnormalities of cardiac hormones...pdfsaleeemmalik259
 
Antihypertensive drugs.pdf
Antihypertensive drugs.pdfAntihypertensive drugs.pdf
Antihypertensive drugs.pdfAxmedXBullaale
 
Antihypertensive mbbs copy
Antihypertensive mbbs   copyAntihypertensive mbbs   copy
Antihypertensive mbbs copyDivya Krishnan
 
PATHOPHYSILOGY OF HYPERTENSION
PATHOPHYSILOGY OF HYPERTENSIONPATHOPHYSILOGY OF HYPERTENSION
PATHOPHYSILOGY OF HYPERTENSIONshivangimistry3
 
Reaction Paper On Ramipril
Reaction Paper On RamiprilReaction Paper On Ramipril
Reaction Paper On RamiprilOlga Bautista
 
Renin-Angiotensin Aldosterone system
Renin-Angiotensin Aldosterone systemRenin-Angiotensin Aldosterone system
Renin-Angiotensin Aldosterone system軒名 林
 
Drugs acting on Renin Angiotensin Aldosterone system
Drugs acting on Renin Angiotensin Aldosterone system Drugs acting on Renin Angiotensin Aldosterone system
Drugs acting on Renin Angiotensin Aldosterone system Dr Htet
 
TỐI ƯU HÓA ĐIỀU TRỊ TĂNG HUYẾT ÁP VỚI THUỐC CHẸN THỤ THỂ AT1 TRONG LIỆU PHÁP ...
TỐI ƯU HÓA ĐIỀU TRỊ TĂNG HUYẾT ÁP VỚI THUỐC CHẸN THỤ THỂ AT1 TRONG LIỆU PHÁP ...TỐI ƯU HÓA ĐIỀU TRỊ TĂNG HUYẾT ÁP VỚI THUỐC CHẸN THỤ THỂ AT1 TRONG LIỆU PHÁP ...
TỐI ƯU HÓA ĐIỀU TRỊ TĂNG HUYẾT ÁP VỚI THUỐC CHẸN THỤ THỂ AT1 TRONG LIỆU PHÁP ...SoM
 
hypertension anesthesia, general management. antihypertensive pharmacology
hypertension anesthesia, general management. antihypertensive pharmacologyhypertension anesthesia, general management. antihypertensive pharmacology
hypertension anesthesia, general management. antihypertensive pharmacologyAbayneh Belihun
 
Recent Advancements in the treatment of Hypertension.
Recent Advancements  in the treatment of Hypertension.Recent Advancements  in the treatment of Hypertension.
Recent Advancements in the treatment of Hypertension.Akshata Darandale
 

Similar a Dr. harman vasopeptidase inhibition (20)

ARNI in Heart Failure Management
ARNI in Heart Failure ManagementARNI in Heart Failure Management
ARNI in Heart Failure Management
 
Hypertension according to latest clinical advances
Hypertension according to latest clinical advances Hypertension according to latest clinical advances
Hypertension according to latest clinical advances
 
2. Antihypertensive Drugs-MSN.pdf
2. Antihypertensive Drugs-MSN.pdf2. Antihypertensive Drugs-MSN.pdf
2. Antihypertensive Drugs-MSN.pdf
 
Cardio-Renal Protection Through Renin–Angiotensin–Aldosterone System Inhibition
Cardio-Renal Protection Through Renin–Angiotensin–Aldosterone System InhibitionCardio-Renal Protection Through Renin–Angiotensin–Aldosterone System Inhibition
Cardio-Renal Protection Through Renin–Angiotensin–Aldosterone System Inhibition
 
Rupajit Bhattacharjee hypertension management
Rupajit Bhattacharjee hypertension management Rupajit Bhattacharjee hypertension management
Rupajit Bhattacharjee hypertension management
 
Abnormalities of cardiac hormones...pdf
Abnormalities of cardiac hormones...pdfAbnormalities of cardiac hormones...pdf
Abnormalities of cardiac hormones...pdf
 
Antihypertensive drugs.pdf
Antihypertensive drugs.pdfAntihypertensive drugs.pdf
Antihypertensive drugs.pdf
 
Antihypertensive mbbs copy
Antihypertensive mbbs   copyAntihypertensive mbbs   copy
Antihypertensive mbbs copy
 
PATHOPHYSILOGY OF HYPERTENSION
PATHOPHYSILOGY OF HYPERTENSIONPATHOPHYSILOGY OF HYPERTENSION
PATHOPHYSILOGY OF HYPERTENSION
 
Reaction Paper On Ramipril
Reaction Paper On RamiprilReaction Paper On Ramipril
Reaction Paper On Ramipril
 
Antihipertensivos
AntihipertensivosAntihipertensivos
Antihipertensivos
 
A2
A2A2
A2
 
PAH management
PAH managementPAH management
PAH management
 
Renin-Angiotensin Aldosterone system
Renin-Angiotensin Aldosterone systemRenin-Angiotensin Aldosterone system
Renin-Angiotensin Aldosterone system
 
Innovations in the Diagnosis and Treatment of Chronic Heart Failure
Innovations in the Diagnosis and Treatment of Chronic Heart FailureInnovations in the Diagnosis and Treatment of Chronic Heart Failure
Innovations in the Diagnosis and Treatment of Chronic Heart Failure
 
Hypertension+clinical
Hypertension+clinicalHypertension+clinical
Hypertension+clinical
 
Drugs acting on Renin Angiotensin Aldosterone system
Drugs acting on Renin Angiotensin Aldosterone system Drugs acting on Renin Angiotensin Aldosterone system
Drugs acting on Renin Angiotensin Aldosterone system
 
TỐI ƯU HÓA ĐIỀU TRỊ TĂNG HUYẾT ÁP VỚI THUỐC CHẸN THỤ THỂ AT1 TRONG LIỆU PHÁP ...
TỐI ƯU HÓA ĐIỀU TRỊ TĂNG HUYẾT ÁP VỚI THUỐC CHẸN THỤ THỂ AT1 TRONG LIỆU PHÁP ...TỐI ƯU HÓA ĐIỀU TRỊ TĂNG HUYẾT ÁP VỚI THUỐC CHẸN THỤ THỂ AT1 TRONG LIỆU PHÁP ...
TỐI ƯU HÓA ĐIỀU TRỊ TĂNG HUYẾT ÁP VỚI THUỐC CHẸN THỤ THỂ AT1 TRONG LIỆU PHÁP ...
 
hypertension anesthesia, general management. antihypertensive pharmacology
hypertension anesthesia, general management. antihypertensive pharmacologyhypertension anesthesia, general management. antihypertensive pharmacology
hypertension anesthesia, general management. antihypertensive pharmacology
 
Recent Advancements in the treatment of Hypertension.
Recent Advancements  in the treatment of Hypertension.Recent Advancements  in the treatment of Hypertension.
Recent Advancements in the treatment of Hypertension.
 

Dr. harman vasopeptidase inhibition

  • 1. Vasopeptidase Inhibition: A New Direction in Cardiovascular Treatment . By: Dr. HARMANJIT SINGH MD STUDENT , GMC , PATIALA
  • 2.
  • 3.
  • 4.
  • 5. Treatment strategies by risk stratification and risk group categories in patients with hypertension BP stages (mm Hg) Treatment Strategy Risk Group A Risk Group B Risk Group C High-Normal (130-139 / 85-89) Lifestyle modification Lifestyle modification Drug therapy, Lifestyle modification Stage 1 (140-159 / 90-99) Lifestyle modification upto 12 months Lifestyle modification upto 6 months (patients with multiple factors should receive drug therapy + lifestyle modification) Drug therapy, lifestyle modification Stage 2 & 3 (> 160 / > 100) Drug therapy, lifestyle modification Drug therapy + lifestyle modification Drug therapy + lifestyle modification
  • 6.
  • 7.
  • 8. Figure 1 showing role of RAS system in cardiovascular disease
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17. Figure 2 showing the benefits of inhibiting NEP
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23. Figure 3 showing combined pathways involved in vasopeptidase inhibition
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.  
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.